Venezuela Medical Device Regulation: IVA, IGTF and Tax Unit Costs

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Import charges in Venezuela consist of three components: customs duty (at the ad valorem rate in the tariff), value added tax (IVA, standard rate 16%), and the large financial transactions tax (IGTF), a surcharge on payments made in foreign currency or cryptocurrency. Fines and certain fees are denominated in tax units (Unidad Tributaria, UT).

The conclusion is that because the bolivar value of the UT is adjusted periodically and the local currency continues to depreciate, nominal amounts expressed in local currency keep moving while the real burden expressed in foreign currency stays relatively stable. Budgeting should therefore be anchored to the UT or to a foreign currency, not to a bolivar figure captured on the day the budget was written.

A second conclusion is that tax cost is only one of the costs created by the tax system. The other is time: exemption lists expire, rates change by decree and certificates have to be obtained before a benefit can be claimed. A budget that models the rates correctly but assumes the entitlement is permanent will still be wrong within a year.

2. Legal basis

InstrumentReferencePublication dateProvision / key point
Ley del IVA (VAT Law)Currently in force—Standard rate 16%; luxury goods surcharge up to 25%
Ley del IGTF (Large Financial Transactions Tax Law)Currently in force—Surcharge on payments in foreign currency or cryptocurrency
Código Orgánico Tributario (Organic Tax Code)Currently in force—Fines denominated in tax units (UT); records kept for 6 years
Decreto N° 4.944 (customs tariff)G.O. N° 6.804 Extraordinario25 April 2024Article 37: ad valorem duty and Common External Tariff exception
Decreto N° 5.146 (customs exemption)G.O. N° 6.918 Extraordinario30 June 2025Duty and IVA relief for goods under specified codes, valid for 1 year

Basis note: the IVA rate has been adjusted several times by administrative decree, and both the rate and the scope of the IGTF have also been adjusted. The applicable rate must be verified for each project; the 16% and 25% figures in the table are a framework description and are marked as a practical estimate.

3. Expert insights

Insight 1: the two-layer structure of rates and units of account is the key to reading Venezuelan tax costs. A rate is a proportion (16% IVA), while a unit of account is the UT (used for fines and certain fixed amounts). The first moves with the transaction value; the second moves with the bolivar value of the UT. Budgeting has to account for both, and modelling only one of them produces a distorted result. A project that models IVA carefully but ignores UT-denominated penalties will understate the cost of any compliance failure, and compliance failures are precisely the events that occur under schedule pressure.

Insight 2: the IGTF bears directly on transactions settled in US dollars. The IGTF is levied on payments made in foreign currency or cryptocurrency. The Venezuelan economy is heavily dollarized and most significant transactions are quoted and settled in dollars, so the IGTF is a cost that necessarily arises in actual trading rather than an optional one that can be avoided by choosing another payment route. It should be built into the landed cost calculation from the start, at the rate applicable on the payment date.

Insight 3: the customs exemption regime operates as a list plus a time limit. Decreto N° 5.146 (30 June 2025, G.O. N° 6.918 Extraordinario) grants duty and IVA relief for goods under the codes listed in its annex, and it is valid for 1 year from publication in the Official Gazette. Exemptions of this kind have a defined lifespan, so eligibility has to be re-verified period by period, and the successor arrangement confirmed before expiry rather than after it.

Insight 4: CNP and CNPI certificates are preconditions for tax benefits. The certificate of non-domestic production (CNP) or of insufficient domestic production (CNPI) is used to obtain the tax benefits available under the VAT Law and the Organic Customs Law. Since July 2025, both certificates are obtained through COMEX. The change runs in the same direction as the platform mandate: a benefit that used to be pursued through a separate office is now part of the same digital estate, which shortens the route but also makes the certificate visible to every agency connected to the platform.

Insight 5: the record retention duty runs for 6 years. Under the Organic Tax Code, records must generally be kept for 6 years from the date of the relevant tax declaration. That sets a defined archive period for import documents and payment receipts, and it applies whether or not the project is still active. Archive policy should therefore be set by tax rule rather than by project lifecycle, since a project that closes in year two still generates a retention duty that runs to year eight.

4. Practical recommendations

  1. Build the budget on two tracks, in UT and in US dollars; treat bolivar amounts as reference figures only, never as the basis for a decision.
  2. Re-verify each period whether the customs exemption list has been extended (for example the 1-year validity of Decreto N° 5.146), and confirm the successor arrangement before expiry.
  3. If a tax benefit is intended, obtain the CNP or CNPI certificate through COMEX in advance (available since July 2025).
  4. Archive import documents and payment receipts against a 6-year retention period, and do not destroy them when a project closes.
  5. Quote and contract in US dollars, and include a clause that allocates the effect of exchange rate and tax burden changes between the parties.

5. Verification checklist

  • □ The current IVA rate and the scope of the IGTF have been verified
  • □ The budget is prepared on both a UT and a US dollar track
  • □ It has been verified whether the product falls within the customs exemption list and, if so, for how long
  • □ CNP or CNPI certificates have been obtained through COMEX, where applicable
  • □ The document archive period is set at 6 years

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers and authorized representatives with registration work in Venezuela, including tax and duty cost modelling, exemption eligibility review and CNP or CNPI processing through COMEX. Whether you need a landed cost model or hands-on filing support, our regulatory team can help. Contact us at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail